Infection in Organ-Transplant Recipients
- 11 June 1998
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 338 (24) , 1741-1751
- https://doi.org/10.1056/nejm199806113382407
Abstract
A primary goal in organ transplantation is the prevention or effective treatment of infection, the most common life-threatening complication of long-term immunosuppressive therapy. The challenges involved in achieving this goal are several: a broad range of potential sources of infection ranging from latent viruses to pathogens of both community and hospital origin; immunosuppression-induced impairment of the inflammatory response, which attenuates the signs and symptoms of invasive infection; and the adverse effects of the antimicrobial drugs used for prophylaxis and therapy, which result both from the duration of therapy required and from interactions with the immunosuppressive drugs cyclosporine and tacrolimus. Our . . .Keywords
This publication has 70 references indexed in Scilit:
- Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patientsDiagnostic Microbiology and Infectious Disease, 1996
- Early intragraft inflammatory events of liver allografts leading to chronic rejectionTransplant International, 1995
- COINCIDENCE OF EPSTEIN-BARR VIRUS REACTIVATION, CYTOMEGALOVIRUS INFECTION, AND REJECTION EPISODES IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1995
- IN SITU PRODUCTION OF INTERLEUKIN-6 WITHIN HUMAN LUNG ALLOGRAFTS DISPLAYING REJECTION OR CYTOMEGALOVIRUS PNEUMONIATransplantation, 1993
- Immunohistochemical Detection of Viral Antigens in Smooth Muscle, Stromal, and Epithelial Cells from Acute Human Cytomegalovirus GastritisThe Journal of Infectious Diseases, 1993
- Preemptive Therapy in Immunocompromised HostsNew England Journal of Medicine, 1991
- Clinical Pharmacokinetics in Organ Transplant PatientsClinical Pharmacokinetics, 1989
- Complement activation during an active cytomegalovirus infection after renal transplantation: Due to circulating immune complexes or alternative pathway activation?Clinical Immunology and Immunopathology, 1989
- Coccidioidomycosis in renal replacement therapyArchives of internal medicine (1960), 1982
- Glomerulopathy Associated with Cytomegalovirus Viremia in Renal AllograftsNew England Journal of Medicine, 1981